Literature DB >> 23686771

Mutations in TNK2 in severe autosomal recessive infantile onset epilepsy.

Yuki Hitomi1, Erin L Heinzen, Simona Donatello, Hans-Henrik Dahl, John A Damiano, Jacinta M McMahon, Samuel F Berkovic, Ingrid E Scheffer, Benjamin Legros, Myriam Rai, Sarah Weckhuysen, Arvid Suls, Peter De Jonghe, Massimo Pandolfo, David B Goldstein, Patrick Van Bogaert, Chantal Depondt.   

Abstract

We identified a small family with autosomal recessive, infantile onset epilepsy and intellectual disability. Exome sequencing identified a homozygous missense variant in the gene TNK2, encoding a brain-expressed tyrosine kinase. Sequencing of the coding region of TNK2 in 110 patients with a similar phenotype failed to detect further homozygote or compound heterozygote mutations. Pathogenicity of the variant is supported by the results of our functional studies, which demonstrated that the variant abolishes NEDD4 binding to TNK2, preventing its degradation after epidermal growth factor stimulation. Definitive proof of pathogenicity will require confirmation in unrelated patients.
Copyright © 2013 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23686771      PMCID: PMC4527160          DOI: 10.1002/ana.23934

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  16 in total

1.  Expression pattern of ACK1 tyrosine kinase during brain development in the mouse.

Authors:  Anna La Torre; José Antonio del Rio; Eduardo Soriano; Jesús Mariano Ureña
Journal:  Gene Expr Patterns       Date:  2006-06-05       Impact factor: 1.224

2.  A human protein-protein interaction network: a resource for annotating the proteome.

Authors:  Ulrich Stelzl; Uwe Worm; Maciej Lalowski; Christian Haenig; Felix H Brembeck; Heike Goehler; Martin Stroedicke; Martina Zenkner; Anke Schoenherr; Susanne Koeppen; Jan Timm; Sascha Mintzlaff; Claudia Abraham; Nicole Bock; Silvia Kietzmann; Astrid Goedde; Engin Toksöz; Anja Droege; Sylvia Krobitsch; Bernhard Korn; Walter Birchmeier; Hans Lehrach; Erich E Wanker
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

3.  Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1.

Authors:  Edward Htun van der Horst; Yan Y Degenhardt; Astrid Strelow; Anthony Slavin; Lawrence Chinn; Jessica Orf; Minqing Rong; Shyun Li; Lei-Hoon See; Ken Q C Nguyen; Timothy Hoey; Holger Wesche; Scott Powers
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-24       Impact factor: 11.205

4.  Expression, synaptic localization, and developmental regulation of Ack1/Pyk1, a cytoplasmic tyrosine kinase highly expressed in the developing and adult brain.

Authors:  Jesús Mariano Ureña; Anna La Torre; Albert Martínez; Eve Lowenstein; Neus Franco; Raphaelle Winsky-Sommerer; Xavier Fontana; Ricardo Casaroli-Marano; Miguel Angel Ibáñez-Sabio; Marta Pascual; José Antonio Del Rio; Luis de Lecea; Eduardo Soriano
Journal:  J Comp Neurol       Date:  2005-09-19       Impact factor: 3.215

5.  Febrile seizures are associated with mutation of seizure-related (SEZ) 6, a brain-specific gene.

Authors:  Zhi-Liang Yu; Jiang-Ming Jiang; Dan-Hong Wu; Hui-Jun Xie; Jin-Jin Jiang; Lin Zhou; Ling Peng; Guan-Shui Bao
Journal:  J Neurosci Res       Date:  2007-01       Impact factor: 4.164

6.  The Sequence Alignment/Map format and SAMtools.

Authors:  Heng Li; Bob Handsaker; Alec Wysoker; Tim Fennell; Jue Ruan; Nils Homer; Gabor Marth; Goncalo Abecasis; Richard Durbin
Journal:  Bioinformatics       Date:  2009-06-08       Impact factor: 6.937

7.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

Review 8.  Advances on the genetics of mendelian idiopathic epilepsies.

Authors:  Stéphanie Baulac; Michel Baulac
Journal:  Neurol Clin       Date:  2009-11       Impact factor: 3.806

9.  The Role of Seizure-Related SEZ6 as a Susceptibility Gene in Febrile Seizures.

Authors:  John C Mulley; Xenia Iona; Bree Hodgson; Sarah E Heron; Samuel F Berkovic; Ingrid E Scheffer; Leanne M Dibbens
Journal:  Neurol Res Int       Date:  2011-07-16

10.  TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells.

Authors:  Jillian Howlin; Jeanette Rosenkvist; Tommy Andersson
Journal:  Breast Cancer Res       Date:  2008-04-24       Impact factor: 6.466

View more
  6 in total

1.  Whole-Exome Sequencing in Familial Parkinson Disease.

Authors:  Janice L Farlow; Laurie A Robak; Kurt Hetrick; Kevin Bowling; Eric Boerwinkle; Zeynep H Coban-Akdemir; Tomasz Gambin; Richard A Gibbs; Shen Gu; Preti Jain; Joseph Jankovic; Shalini Jhangiani; Kaveeta Kaw; Dongbing Lai; Hai Lin; Hua Ling; Yunlong Liu; James R Lupski; Donna Muzny; Paula Porter; Elizabeth Pugh; Janson White; Kimberly Doheny; Richard M Myers; Joshua M Shulman; Tatiana Foroud
Journal:  JAMA Neurol       Date:  2016-01       Impact factor: 18.302

Review 2.  Lessons learned from gene identification studies in Mendelian epilepsy disorders.

Authors:  Katia Hardies; Sarah Weckhuysen; Peter De Jonghe; Arvid Suls
Journal:  Eur J Hum Genet       Date:  2015-11-25       Impact factor: 4.246

Review 3.  ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers.

Authors:  K Mahajan; N P Mahajan
Journal:  Oncogene       Date:  2014-10-27       Impact factor: 9.867

4.  ACK1 is dispensable for development, skin tumor formation, and breast cancer cell proliferation.

Authors:  Rafael Brandao; Mei Qi Kwa; Yossi Yarden; Cord Brakebusch
Journal:  FEBS Open Bio       Date:  2021-05-02       Impact factor: 2.693

5.  The sacred disease: the puzzling genetics of epileptic disorders.

Authors:  Gaia Novarino; Seung Tae Baek; Joseph G Gleeson
Journal:  Neuron       Date:  2013-10-02       Impact factor: 17.173

6.  De novo mutations in epileptic encephalopathies.

Authors:  Andrew S Allen; Samuel F Berkovic; Patrick Cossette; Norman Delanty; Dennis Dlugos; Evan E Eichler; Michael P Epstein; Tracy Glauser; David B Goldstein; Yujun Han; Erin L Heinzen; Yuki Hitomi; Katherine B Howell; Michael R Johnson; Ruben Kuzniecky; Daniel H Lowenstein; Yi-Fan Lu; Maura R Z Madou; Anthony G Marson; Heather C Mefford; Sahar Esmaeeli Nieh; Terence J O'Brien; Ruth Ottman; Slavé Petrovski; Annapurna Poduri; Elizabeth K Ruzzo; Ingrid E Scheffer; Elliott H Sherr; Christopher J Yuskaitis; Bassel Abou-Khalil; Brian K Alldredge; Jocelyn F Bautista; Samuel F Berkovic; Alex Boro; Gregory D Cascino; Damian Consalvo; Patricia Crumrine; Orrin Devinsky; Dennis Dlugos; Michael P Epstein; Miguel Fiol; Nathan B Fountain; Jacqueline French; Daniel Friedman; Eric B Geller; Tracy Glauser; Simon Glynn; Sheryl R Haut; Jean Hayward; Sandra L Helmers; Sucheta Joshi; Andres Kanner; Heidi E Kirsch; Robert C Knowlton; Eric H Kossoff; Rachel Kuperman; Ruben Kuzniecky; Daniel H Lowenstein; Shannon M McGuire; Paul V Motika; Edward J Novotny; Ruth Ottman; Juliann M Paolicchi; Jack M Parent; Kristen Park; Annapurna Poduri; Ingrid E Scheffer; Renée A Shellhaas; Elliott H Sherr; Jerry J Shih; Rani Singh; Joseph Sirven; Michael C Smith; Joseph Sullivan; Liu Lin Thio; Anu Venkat; Eileen P G Vining; Gretchen K Von Allmen; Judith L Weisenberg; Peter Widdess-Walsh; Melodie R Winawer
Journal:  Nature       Date:  2013-08-11       Impact factor: 49.962

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.